Sandu Pharmaceuticals Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Sandu Pharmaceuticals Ltd is ₹ 42.11 as of 05 May 15:30 . The P/E Ratio of Sandu Pharmaceuticals Ltd is 33.3 as of March 2023 .The P/E Ratio of Sanofi Consumer Healthcare India Ltd is 0 as of March 2023 . The Market Cap of Sandu Pharmaceuticals Ltd is ₹ 50.43 crore as of March 2023 .The Market Cap of Sanofi Consumer Healthcare India Ltd is ₹ 0 crore as of March 2023 . The revenue of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 14.14 crore as compare to the Dec '24 revenue of ₹ 18.4 crore. This represent the decline of -23.15% The revenue of Sanofi Consumer Healthcare India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 0.52 crore as compare to the Dec '24 ebitda of ₹ 1.02 crore. This represent the decline of -49.02% The ebitda of Sanofi Consumer Healthcare India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sandu Pharmaceuticals Ltd changed from ₹ 0.17 crore to ₹ 0.33 crore over 4 quarters. This represents a CAGR of 94.12% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 0 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of 0.0% The Dividend Payout of Sandu Pharmaceuticals Ltd changed from 36.33 % on March 2021 to 0 % on December 2024 . This represents a CAGR of -100.00% over 7 yearsThe Dividend Payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % on December 2023 to 69.89 % on December 2024 . This represents a CAGR of 239.60% over 2 years .

About Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Ltd (SPL) was established in 1985.
The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.
Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

FAQs for the comparison of Sandu Pharmaceuticals Ltd and Sanofi Consumer Healthcare India Ltd

Which company has a larger market capitalization, Sandu Pharmaceuticals Ltd or Sanofi Consumer Healthcare India Ltd?

Market cap of Sandu Pharmaceuticals Ltd is 40 Cr while Market cap of Sanofi Consumer Healthcare India Ltd is 10,577 Cr

What are the key factors driving the stock performance of Sandu Pharmaceuticals Ltd and Sanofi Consumer Healthcare India Ltd?

The stock performance of Sandu Pharmaceuticals Ltd and Sanofi Consumer Healthcare India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sandu Pharmaceuticals Ltd and Sanofi Consumer Healthcare India Ltd?

As of May 5, 2026, the Sandu Pharmaceuticals Ltd stock price is INR ₹42.11. On the other hand, Sanofi Consumer Healthcare India Ltd stock price is INR ₹4592.6.

How do dividend payouts of Sandu Pharmaceuticals Ltd and Sanofi Consumer Healthcare India Ltd compare?

To compare the dividend payouts of Sandu Pharmaceuticals Ltd and Sanofi Consumer Healthcare India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.